Aparicio, Jorge
Virgili Manrique, Anna C.
Capdevila, Jaume
Muñoz Boza, Félix
Galván, Patricia
Richart, Paula
Oliveres, Helena
Páez, David
Hernando, Jorge
Serrano, Sara
Vera, Ruth
Hernandez-Yagüe, Xavier
Gallego, Rafael Álvarez
Riesco-Martinez, M. Carmen
García de Albeniz, Xavier
Maurel, Joan http://orcid.org/0000-0002-9413-5592
Article History
Received: 11 April 2022
Accepted: 27 May 2022
First Online: 27 June 2022
Declarations
:
: Dr J. Aparicio received honoraria for consultant or advisory role for Amgen, Merck, Sanofi, Servier, Bayer and Pierre Fabre. Dr A.C. Virgili reported serving on speakers´ bureaus for Amgen, Sanofi, and Servier; received honoraria for scientific advisory role from Roche and Amgen; and receiving travel grants from Merck, Roche, Amgen, Sanofi, MSD, and Servier. Dr J. Capdevila reported receiving honoraria for serving on speakers´ bureaus and scientific advisory from Amgen, Bayer, AAA, AstraZeneca, Eisai, Exelixis, Ipsen, ITM, Hudchinson Pharma, Lilly, Novartis, Pfizer, and Sanofi; and receiving research grants from AAA, Eisai, Ipsen, Novartis, and Pfizer. Dr D. Paez reported receiving honoraria from Amgen, Sanofi, and Novartis; for serving in advisory roles from Amgen, Ipsen, and Servier; reported receiving research funding from Merck; and reported receiving travel grants from Amgen, Merck, Roche, Lilly, Servier, Sanofi, and Ipsen. Dr J. Hernando reported receiving honoraria from speakers´ bureaus from Ipsen, Eisai, Novartis, Adacap, Leo, Angelini, Roche, and Pfizer. Dr R. Vera received consultant fees from Roche, Amgen, Merck, Sanofi, and Bristol Myer Squibb; and received advisory honorarium from Roche, Amgen, Merck Sharp, and Dohme and Sanofi. Dr X. Hernandez-Yagüe reported receiving honoraria for serving in an advisory role from Sanofi, Amgen, and Merck. Dr J. Maurel received research grants from Merck, Roche, Amgen, NanoString, Incyte, and Biocartis; reported personal fees from Advance Medical, Cancer Expert Now, Fundación Clínica Universitaria, Sirtex, Pierre-Fabre, Shire, Astra-Zeneca, Bayer, Servier, Sanofi, and Roche; and received grants from Catalan Agency for Management of University and Research Grants (AGAUR) (2014-SGR-474 and 2017-SGR-1174), Fundació la Marató de TV3 (201330.10), Instituto de Salud Carlos III (PI13/01728 and PI19/00740), Fundacion Olga Torres (Modalitat A. 2019/2020), and Spanish Association Against Cancer (AECC, PROYE19040POST_001). All remaining authors have declared no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from the patient included in the case report.